Sandoz Will Not Pursue US Advair Rival

Discontinuing Development Leads To $442m Impairment

 
• By David Wallace
  
Sportsman_Tired
Sandoz has given up on the race for a generic version of Advair Diskus • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business